1.
Long J, Xie S, Zhang W, Dou W, Wang Y, Wang R, Liu H, Xu Z. The nuclear factor-κ B inhibitor SN50 enhances the efficacy of B-cell maturation antigen-targeted chimeric antigen receptor T-cell therapy. haematol [Internet]. 2025Jun.1 [cited 2025Jun.13];110(6):1412-6. Available from: https://haematologica.org/article/view/11912